What is the maximum dose of synchronized defibrillation for an adult patient in cardiac emergency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Synchronized Cardioversion

The maximum dose for synchronized cardioversion in adults is 200 J for biphasic waveforms, though synchronized cardioversion should never be used for ventricular fibrillation or pulseless ventricular tachycardia—these require unsynchronized defibrillation at maximum available energy (typically 360 J for monophasic or 200 J for biphasic). 1, 2

Critical Distinction: Synchronized vs Unsynchronized Shocks

The term "synchronized defibrillation" requires immediate clarification because it represents a fundamental safety issue:

  • Synchronized cardioversion is used only for organized rhythms with a pulse (stable or unstable VT with pulse, atrial fibrillation, atrial flutter, SVT) 2
  • Unsynchronized defibrillation is used for pulseless rhythms (VF, pulseless VT) 1, 2

Never use synchronized mode for VF or pulseless VT—the device may fail to sense a QRS complex and deliver no shock at all, wasting critical seconds during cardiac arrest. 2

Maximum Energy Doses by Clinical Scenario

For Unstable Monomorphic VT With a Pulse (Synchronized)

  • Initial dose: 100 J (biphasic or monophasic) 1, 2
  • Subsequent doses: Escalate stepwise if initial shock fails 1, 2
  • Maximum practical dose: 200 J for biphasic waveforms 1

For VF or Pulseless VT (Unsynchronized Defibrillation)

  • Biphasic waveforms: 120-200 J initially (manufacturer-specific), with maximum dose available for subsequent shocks 1
  • Monophasic waveforms: 360 J for all shocks 1
  • If manufacturer's dose unknown: Use maximal dose available 1

For Polymorphic VT (Unsynchronized)

  • Treat as VF with unsynchronized high-energy shocks—never use synchronized mode even if pulse present 2
  • Use same energy doses as VF (120-200 J biphasic or 360 J monophasic) 1

Energy Escalation Protocol

For subsequent shocks in refractory VF/pulseless VT, energy should be at least equivalent to the first shock, and higher energy levels should be considered if the defibrillator is capable. 1

Recent evidence shows:

  • Escalating energy regimens (200-300-360 J) demonstrate superior sustained VF termination compared to fixed lower-energy protocols for refractory rhythms requiring multiple shocks 3, 4
  • First shock success rates are similar between fixed and escalating protocols (86-93% termination), but escalating energy improves outcomes for second and subsequent shocks 3, 5, 4
  • The 2015 AHA guidelines acknowledge this evidence, recommending equivalent or higher energy for subsequent attempts 1

Common Pitfalls to Avoid

Never delay shock delivery to switch between synchronized and unsynchronized modes during cardiac arrest—pulseless rhythms always require immediate unsynchronized defibrillation 1, 2

Never use synchronized cardioversion for:

  • Ventricular fibrillation (device cannot sense QRS) 2
  • Pulseless ventricular tachycardia (delays treatment of cardiac arrest) 2
  • Polymorphic VT even with pulse (synchronization usually impossible) 2

For biphasic defibrillators, the "maximum dose" varies by manufacturer (typically 200 J for most devices), so providers should know their equipment specifications 1

Resume CPR immediately after any shock delivery without pausing for rhythm or pulse checks—continue for 2 minutes before next rhythm assessment 1

Pediatric Considerations

For children with VF or pulseless VT:

  • First shock: 2 J/kg 1
  • Second shock: 4 J/kg 1
  • Subsequent shocks: 4-10 J/kg, not to exceed adult maximum dose 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.